Now showing items 11-20 of 671
Updated Clinical Classification of Pulmonary Hypertension
(ELSEVIER SCIENCE INC, 2009)
The aim of a clinical classification of pulmonary hypertension (PH) is to group together different manifestations of disease sharing similarities in pathophysiologic mechanisms, clinical presentation, and therapeutic ...
Measurement, interpretation and use of hemodynamic parameters
(CAMBRIDGE UNIV PRESS, 2009)
Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension
(Elsevier Science BvAmsterdamHolanda, 2005)
2-Aminoethyldiphenylborinate modifies the pulmonary circulation in pulmonary hypertensive newborn lambs partially gestated at high altitude
(American Physiological Society, 2016)
© 2016 the American Physiological Society. Calcium signaling through store-operated channels (SOC) is involved in hypoxic pulmonary hypertension. We determined whether a treatment with 2-aminoethyldiphenylborinate (2-APB), ...
Sildenafil for pulmonary hypertension treatment after cardiac surgery
Objective: To report on the use of sildenafil for pulmonary hypertension treatment of a newborn patient after cardiac surgery. Description: A female, full term newborn infant with diagnosis of double outlet right ventricle, ...
Pulmonary Hypertension in Latin America Pulmonary Vascular Disease: The Global Perspective
(AMER COLL CHEST PHYSICIANS, 2010)
Latin America is here defined as all of the Americas south of the United States. In the setting of pulmonary hypertension, there are social inequalities and geophysical aspects in this region that account for a high ...
Effects of different inspired oxygen fractions on sildenafil-induced pulmonary anti-hypertensive effects in a sheep model of acute pulmonary embolism
(Elsevier B.V., 2015-04-15)
Aims: Sildenafil is a pulmonary anti-hypertensive agent whose action could be modified by different fractions of inspired oxygen (FiO(2)). We compared the effects of pure oxygen (FiO(2) > 90%) or room air (21% FiO(2)) ...